Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins
- PMID: 21573992
- DOI: 10.1007/s12013-011-9200-x
Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins
Abstract
The ability of a polypeptide to fold into a unique, functional, and three-dimensional structure depends on the intrinsic properties of the amino acid sequence, function of the molecular chaperones, proteins, and enzymes. Every polypeptide has a finite tendency to misfold and this forms the darker side of the protein world. Partially folded and misfolded proteins that escape the cellular quality control mechanism have the high tendency to form inter-molecular hydrogen bonding between the same protein molecules resulting in aggregation. This review summarizes the underlying and universal mechanism of protein folding. It also deals with the factors responsible for protein misfolding and aggregation. This article describes some of the consequences of such behavior particularly in the context of neurodegenerative conformational diseases such as Alzheimer's, Parkinson's, Huntington's, amyotrophic lateral sclerosis and other non-neurodegenerative conformational diseases such as cancer and cystic fibrosis etc. This will encourage a more proactive approach to the early diagnosis of conformational diseases and nutritional counseling for patients.
Similar articles
-
Protein-misfolding diseases and chaperone-based therapeutic approaches.FEBS J. 2006 Apr;273(7):1331-49. doi: 10.1111/j.1742-4658.2006.05181.x. FEBS J. 2006. PMID: 16689923 Review.
-
Protein folding, misfolding and quality control: the role of molecular chaperones.Essays Biochem. 2014;56:53-68. doi: 10.1042/bse0560053. Essays Biochem. 2014. PMID: 25131586
-
Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.J Toxicol Environ Health A. 2011;74(22-24):1433-59. doi: 10.1080/15287394.2011.618967. J Toxicol Environ Health A. 2011. PMID: 22043906 Review.
-
How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.Pathobiology. 2007;74(3):145-58. doi: 10.1159/000103374. Pathobiology. 2007. PMID: 17643060 Review.
-
[Immunotherapy targeting misfolded proteins in neurodegenerative disease].Brain Nerve. 2013 Apr;65(4):469-74. Brain Nerve. 2013. PMID: 23568995 Review. Japanese.
Cited by
-
Conformational transitions provoked by organic solvents in chicken egg ovalbumin: mimicking the local environment.Protein J. 2013 Jan;32(1):7-14. doi: 10.1007/s10930-012-9453-2. Protein J. 2013. PMID: 23090025
-
Quantitation of Tissue Amyloid via Fluorescence Spectroscopy Using Controlled Concentrations of Thioflavin-S.Molecules. 2023 Jun 1;28(11):4483. doi: 10.3390/molecules28114483. Molecules. 2023. PMID: 37298959 Free PMC article.
-
p62/Sequestosome-1 Is Indispensable for Maturation and Stabilization of Mallory-Denk Bodies.PLoS One. 2016 Aug 15;11(8):e0161083. doi: 10.1371/journal.pone.0161083. eCollection 2016. PLoS One. 2016. PMID: 27526095 Free PMC article.
-
Mechanistic Insight into the Reactivation of BCAII Enzyme from Denatured and Molten Globule States by Eukaryotic Ribosomes and Domain V rRNAs.PLoS One. 2016 Apr 21;11(4):e0153928. doi: 10.1371/journal.pone.0153928. eCollection 2016. PLoS One. 2016. PMID: 27099964 Free PMC article.
-
Eukaryotic Aggresomes: Protocols and Tips for Their Production, Purification , and Handling.Methods Mol Biol. 2022;2406:417-435. doi: 10.1007/978-1-0716-1859-2_25. Methods Mol Biol. 2022. PMID: 35089572
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical